Na Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Internal Medicine top 10%
Papers in
-
- Biofuel production and bioconversion 8
-
- Atrial Fibrillation Management and Outcomes 13
- Cardiac electrophysiology and arrhythmias 5
- Antiplatelet Therapy and Cardiovascular Diseases 4
- Co-authors
- Wenxin Qin (1 shared paper)Xisong Huo (1 shared paper)Haojie Jin (1 shared paper)Xuan Deng (1 shared paper)Cun Wang (1 shared paper)Xin‐Rong Yang (1 shared paper)Lijun Cheng (1 shared paper)Jia Fan (1 shared paper)
- Journals
- Frontiers in Pharmacology (6 papers)Biochemical and Biophysical Research Communications (5 papers)BMC Cancer (3 papers)Annals of Translational Medicine (2 papers)Frontiers in Genetics (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Na Wang
141 papers receiving 2.1k citations
Na Wang's Hit Papers
Peers
Comparison fields: 5 of 153
- Cancer Research 437
- Internal Medicine 43
- Cardiology and Cardiovascular Medicine 212
- Molecular Biology 663
- Geriatrics and Gerontology 29
Countries citing papers authored by Na Wang
This map shows the geographic impact of Na Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Wang more than expected).
Fields of papers citing papers by Na Wang
This network shows the impact of papers produced by Na Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Wang. The network helps show where Na Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Na Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4 Hit paper breakdown → | 2017 | 437 |
| 2 | 2015 | 86 | |
| 3 | 2019 | 72 | |
| 4 | 2017 | 56 | |
| 5 | 2021 | 52 | |
| 6 | 2016 | 51 | |
| 7 | 2021 | 45 | |
| 8 | 2012 | 37 | |
| 9 | 2022 | 34 | |
| 10 | 2015 | 32 | |
| 11 | 2008 | 31 | |
| 12 | 2019 | 29 | |
| 13 | 2011 | 29 | |
| 14 | 2012 | 28 | |
| 15 | 2016 | 27 | |
| 16 | 2013 | 26 | |
| 17 | 2021 | 24 | |
| 18 | 2016 | 24 | |
| 19 | 2020 | 24 | |
| 20 | 2007 | 24 |
About Na Wang
Na Wang is a scholar working on Biomedical Engineering, Cardiology and Cardiovascular Medicine, Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 152 papers that have together received 2.1k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (13 papers), Lung Cancer Diagnosis and Treatment (9 papers), Biofuel production and bioconversion (8 papers), Lung Cancer Treatments and Mutations (6 papers), Cardiac electrophysiology and arrhythmias (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). The work is most often cited by research in Cancer Research (437 citations), Internal Medicine (43 citations), Cardiology and Cardiovascular Medicine (212 citations), Molecular Biology (663 citations) and Geriatrics and Gerontology (29 citations). Na Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wenxin Qin, Xisong Huo, Haojie Jin, Xuan Deng, Cun Wang, Xin‐Rong Yang, Lijun Cheng, Jia Fan, Hui Wang and Ning Wang. Their work appears in journals such as Frontiers in Pharmacology, Biochemical and Biophysical Research Communications, BMC Cancer, Annals of Translational Medicine and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.